VERIFICACIÓN DE LA HIPÓTESIS

gland function. Mol Cell Biol 26:5809-26.

194. Takeya, R., K. Taniguchi, S. Narumiya, and H. Sumimoto. 2008. The mammalian formin FHOD1 is activated through phosphorylation by ROCK and mediates thrombin-induced stress fibre formation in endothelial cells. Embo J 27:618-28.

195. Treisman, R. 1987. Identification and purification of a polypeptide that binds to the c-fos serum response element. Embo J 6:2711-7.

196. Treisman, R. 1986. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46:567-74. 197. Vartiainen, M. K. 2008. Nuclear actin dynamics - From form to function. FEBS

Lett 582:2033-40.

198. Vartiainen, M. K., S. Guettler, B. Larijani, and R. Treisman. 2007. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science 316:1749-52.

domain (DAD) is required for autoregulatory interactions with the diaphanous- related formin inhibitory domain. J Biol Chem 281:4300-7.

200. Wang, D., P. S. Chang, Z. Wang, L. Sutherland, J. A. Richardson, E. Small, P. A. Krieg, and E. N. Olson. 2001. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105:851-62. 201. Wang, D. Z., S. Li, D. Hockemeyer, L. Sutherland, Z. Wang, G. Schratt, J. A.

Richardson, A. Nordheim, and E. N. Olson. 2002. Potentiation of serum response factor activity by a family of myocardin- related transcription factors. Proc Natl Acad Sci U S A 99:14855-60.

202. Wang, J., A. Li, Z. Wang, X. Feng, E. N. Olson, and R. J. Schwartz. 2007. Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts. Mol Cell Biol 27:622-32.

203. Wang, L., L. Yang, Y. Luo, and Y. Zheng. 2003. A novel strategy for

specifically down-regulating individual Rho GTPase activity in tumor cells. J Biol Chem 278:44617-25.

204. Wang, Y., M. R. El-Zaru, H. K. Surks, and M. E. Mendelsohn. 2004. Formin homology domain protein (FHOD1) is a cyclic GMP-dependent protein kinase I- binding protein and substrate in vascular smooth muscle cells. J Biol Chem 279:24420-6.

205. Wang, Z., D. Z. Wang, D. Hockemeyer, J. McAnally, A. Nordheim, and E. N. Olson. 2004. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428:185-9.

206. Wang, Z., D. Z. Wang, G. C. Pipes, and E. N. Olson. 2003. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A 100:7129-34.

207. Watanabe, N., P. Madaule, T. Reid, T. Ishizaki, G. Watanabe, A. Kakizuka, Y. Saito, K. Nakao, B. M. Jockusch, and S. Narumiya. 1997. p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin. Embo J 16:3044-56.

208. Weinhold, B., G. Schratt, S. Arsenian, J. Berger, K. Kamino, H. Schwarz, U. Ruther, and A. Nordheim. 2000. Srf(-/-) ES cells display non-cell-autonomous impairment in mesodermal differentiation. Embo J 19:5835-44.

209. Westendorf, J. J. 2001. The formin/diaphanous-related protein, FHOS, interacts with Rac1 and activates transcription from the serum response element. J Biol Chem 276:46453-9.

210. Wilm, B., A. Ipenberg, N. D. Hastie, J. B. Burch, and D. M. Bader. 2005. The serosal mesothelium is a major source of smooth muscle cells of the gut

vasculature. Development 132:5317-28.

211. Wojciak-Stothard, B., and A. J. Ridley. 2003. Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases. J Cell Biol 161:429-39.

212. Wojcikiewicz, R. J., and S. G. Luo. 1998. Phosphorylation of inositol 1,4,5- trisphosphate receptors by cAMP-dependent protein kinase. Type I, II, and III receptors are differentially susceptible to phosphorylation and are phosphorylated in intact cells. J Biol Chem 273:5670-7.

213. Worth, N. F., G. R. Campbell, J. H. Campbell, and B. E. Rolfe. 2004. Rho expression and activation in vascular smooth muscle cells. Cell Motil

Cytoskeleton 59:189-200.

214. Wu, J. I., and G. R. Crabtree. 2007. Cell signaling. Nuclear actin as choreographer of cell morphology and transcription. Science 316:1710-1. 215. Wu, X., T. A. Haystead, R. K. Nakamoto, A. V. Somlyo, and A. P. Somlyo.

1998. Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin. Synergism with cyclic nucleotide-activated kinase. J Biol Chem 273:11362-9.

216. Wu, X., Y. Yoo, N. N. Okuhama, P. W. Tucker, G. Liu, and J. L. Guan. 2006. Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners. Nat Cell Biol 8:756-63.

217. Xu, C. B., J. Hansen-Schwartz, and L. Edvinsson. 2004. Sphingosine signaling and atherogenesis. Acta Pharmacol Sin 25:849-54.

218. Xu, Q. 2008. Stem cells and transplant arteriosclerosis. Circ Res 102:1011-24. 219. Yamaguchi, T., P. Sharma, M. Athanasiou, A. Kumar, S. Yamada, and M. R.

220. Yamamoto, Y., I. Ikegaki, Y. Sasaki, and T. Uchida. 2000. The protein kinase inhibitor fasudil protects against ischemic myocardial injury induced by

endothelin-1 in the rabbit. J Cardiovasc Pharmacol 35:203-11.

221. Yang, E., L. Lerner, D. Besser, and J. E. Darnell, Jr. 2003. Independent and Cooperative Activation of Chromosomal c-fos Promoter by STAT3. J Biol Chem 278:15794-9.

222. Yang, S. H., E. Jaffray, B. Senthinathan, R. T. Hay, and A. D. Sharrocks. 2003. SUMO and transcriptional repression: dynamic interactions between the MAP kinase and SUMO pathways. Cell Cycle 2:528-30.

223. Yang, S. H., and A. D. Sharrocks. 2004. SUMO promotes HDAC-mediated transcriptional repression. Mol Cell 13:611-7.

224. Yang, X., L. H. Castilla, X. Xu, C. Li, J. Gotay, M. Weinstein, P. P. Liu, and C. X. Deng. 1999. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 126:1571-80.

225. Yang, Y., H. Hou, E. M. Haller, S. V. Nicosia, and W. Bai. 2005. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. Embo J 24:1021-32.

226. Yano, H., K. Hayashi, T. Momiyama, H. Saga, M. Haruna, and K. Sobue. 1995. Transcriptional regulation of the chicken caldesmon gene. Activation of gizzard-type caldesmon promoter requires a CArG box-like motif. J Biol Chem 270:23661-6.

227. Yoshida, T., Q. Gan, Y. Shang, and G. K. Owens. 2007. Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. Am J Physiol Cell Physiol 292:C886-95.

228. Yoshida, T., M. H. Hoofnagle, and G. K. Owens. 2004. Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin. Circ Res 94:1075-82.

229. Yoshida, T., S. Sinha, F. Dandre, B. R. Wamhoff, M. H. Hoofnagle, B. E. Kremer, D. Z. Wang, E. N. Olson, and G. K. Owens. 2003. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 92:856-64.

230. Young, J. J. 2007. Neointimal formation following drug-eluting stents:

physiology, timeline, and the influence of drug delivery systems. Rev Cardiovasc Med 8 Suppl 1:S3-10.

231. Yukita, A., T. Michiue, A. Fukui, K. Sakurai, H. Yamamoto, M. Ihara, A. Kikuchi, and M. Asashima. 2004. XSENP1, a novel sumo-specific protease in Xenopus, inhibits normal head formation by down-regulation of Wnt/beta-catenin signalling. Genes Cells 9:723-36.

232. Zargham, R. 2008. Preventing restenosis after angioplasty: a multistage approach. Clin Sci (Lond) 114:257-64.

233. Zhang, H., H. Saitoh, and M. J. Matunis. 2002. Enzymes of the SUMO

modification pathway localize to filaments of the nuclear pore complex. Mol Cell Biol 22:6498-508.

234. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-71.

235. Zhao, K., W. Wang, O. J. Rando, Y. Xue, K. Swiderek, A. Kuo, and G. R. Crabtree. 1998. Rapid and phosphoinositol-dependent binding of the SWI/SNF- like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 95:625-36.

236. Zhou, X., V. M. Richon, A. H. Wang, X. J. Yang, R. A. Rifkind, and P. A. Marks. 2000. Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras. Proc Natl Acad Sci U S A 97:14329-33.